Form 4 for AUPH Aurinia Pharmaceuticals Inc.
Accepted 2026-02-03 00:00:00 ET · period of report 2026-02-02 · accession 0002044006-26-000002 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-02-03 | 2026-02-02 | AUPH | Keenan Greg | SVP, Chief Medical Off | F - Tax | $14.53 | -11.6K | 121.9K | -9% | -$167.9K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-02-02 | F | D | 11,552 | $14.53 | 121,932 | D | — | — | (F1) Represents shares withheld to satisfy tax withholding obligations upon the vesting of restricted stock units. |